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Background. To examine whether the US EPA (2010) lung cancer risk estimate derived from the high arsenic exposures (10–
934 𝜇g/L) in southwest Taiwan accurately predicts the US experience from low arsenic exposures (3–59 𝜇g/L). Methods. Analyses
have been limited to US counties solely dependent on underground sources for their drinking water supply with median arsenic
levels of ≥3 𝜇g/L. Results. Cancer risks (slopes) were found to be indistinguishable from zero for males and females. The addition of
arsenic level did not significantly increase the explanatory power of the models. Stratified, or categorical, analysis yielded relative
risks that hover about 1.00. The unit risk estimates were nonpositive and not significantly different from zero, and the maximum
(95% UCL) unit risk estimates for lung cancer were lower than those in US EPA (2010). Conclusions. These data do not demonstrate
an increased risk of lung cancer associated with median drinking water arsenic levels in the range of 3–59 𝜇g/L. The upper-bound
estimates of the risks are lower than the risks predicted from the SW Taiwan data and do not support those predictions. These results
are consistent with a recent metaregression that indicated no increased lung cancer risk for arsenic exposures below 100–150 𝜇g/L.

Dedicated to the late Arnold Engel, M.D., who co-conceived this study and oversaw the development of the dataset

1. Introduction
Arsenic is a known human carcinogen, whether the exposure
is by ingestion or inhalation. Arsenic ingestion by populations exposed to arsenic concentrations in drinking water
of at least several hundred micrograms per liter (𝜇g/L) is
associated with skin cancer, bladder cancer, and lung cancer
[1]. A number of other sites have isolated positive findings,
but skin, lung, and bladder cancer are consistently found

to be increased with ingestion of high levels of arsenic [1].
The primary strong findings are in the Chilean studies where
major parts of the population had average exposures of 600–
860 𝜇g/L [2] and in the SW Taiwan study where major parts
of the population had high exposures of 300–590 𝜇g/L and
still higher exposures of ≥600 𝜇g/L [3].
Cancer risk estimates for lower levels have generally been
derived by backward extrapolation of risk at high levels.
Cantor has observed that “most estimates of risk at low
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and moderate levels of exposure (<200 𝜇g/L) have been
based on extrapolation from ecological studies of populations
exposed to higher levels” [4]. In February 2010, the US
Environmental Protection Agency (US EPA) circulated a
never-finalized draft toxicological review of inorganic arsenic
which presented unit risks for US male and female lung
cancer incidences [5]. These risks were derived from high
median arsenic exposure levels (mainly 300–934 𝜇g/L) in SW
Taiwan and were presented as being the risks expected to have
been experienced in the US where the population generally
has low arsenic exposure levels (3–59 𝜇g/L) [5].
While most epidemiological studies where drinking
water arsenic levels are in the hundreds of micrograms
arsenic per liter range do indicate a significant strong association for lung cancer [6], few studies report such risks in the
lower range of <100 𝜇g/L. A number of lung cancer studies
showed no significant increased risk below 100 𝜇g/L [7–11],
while others did [2, 12, 13]. Other studies using either toenail
or urine arsenic metrics found no increased risk in their low
exposure groups [14, 15]. This study adds to the developing
literature and provides more data points in the up to 60 𝜇g/L
arsenic range than do any of the other studies.
The current study is analogous to the male bladder cancer
ecological study of 133 US counties (1950–1979) with median
groundwater arsenic levels in the 3–59 𝜇g/L range (measured
in the period 1973–1998) [16]. The bladder cancer study found
no arsenic-related increase in male bladder cancer mortality
in that exposure range. The 95% upper-bound estimate of
the risk was found to be lower than the risk predicted by
the National Research Council (2001) but not that predicted
by the US EPA (2001) [17, 18]. The NRC (2001) and US EPA
(2001) risks had been based on Morales et al.’s (2000) dataset
[19] for the 42-village study from SW Taiwan where median
exposures ranged up to 934 𝜇g/L presented in the NRC (2001)
Table A10-1 [17–19].
This analysis of US counties lung cancer mortality
expands upon that analysis of US counties bladder cancer
mortality [16]. Specifically, it uses the same exposure and
outcome data but now for lung cancer, for males and for
females, and for a greater number of counties.
Further, we were able to obtain county-specific covariable
information that had not been available ten years earlier.
Finally, we were able to compare the 95% confidence limits
based on the US observations and compared the upperbound estimate with that predicted by the more recent US
EPA [5, page 131].

2. Materials and Methods
This study is an ecological study with the goal of assessing
the association between arsenic in drinking water and lung
cancer. This study combined the county-specific median
arsenic groundwater data from the US Geological Survey
(USGS) [20] with the county-specific lung cancer mortality
data for the period 1950 to 1979 from the National Cancer
Institute (NCI) and US Environmental Protection Agency
[21]. It was limited to those counties assessed by their state
departments of health or of the environment to be solely
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dependent on groundwater for their drinking water supply,
that is, having no surface water sources.
2.1. Exposure Measure. The exposure data come from the
USGS National Water Information System [20] dataset that
contained arsenic measurements from 67,440 wells with
potable water. The data were collected in 1973–1998 and
released in November 2001. The assessments of groundwater
arsenic levels were made in the late 20th century and are
assumed to reflect the groundwater arsenic levels back to
the early 20th century. These are the earliest known national
groundwater arsenic data.
USGS [20] developed a set of county-specific summary
statistics of arsenic levels in potable groundwater well sources
in 𝜇g/L. The summary statistics included the median, mean,
and maximum values, as well as 10th percentile, 75th percentile, and 90th percentile levels for each county with sufficient data—each determined by USGS. Counties with fewer
than five wells within 50 km radius of the center of the county
were considered to have insufficient data for the calculation
of summary statistics. This analysis only includes counties
which the USGS [20] considered to have sufficient number
of well sources to develop county-specific summary statistics.
For each well, the latest specimen was used. All of these
measurements had been made using hydride generation.
USGS [20] assigned a representative median arsenic
concentration to each county, and we have used those countyspecific values. There is no breakdown of subpopulations
within the counties, so the median arsenic concentration is
assumed to represent the exposure of the entire population.
Of the 2,277 counties, 1,594 had sufficient data for computing
summary statistics with medians of 1 𝜇g/L to 59 𝜇g/L and
682 did not. In parallel to the 2004 report on US bladder
cancer mortality and groundwater arsenic levels, selection
was limited to the counties with a median of 3 𝜇g/L arsenic
or higher (𝑁 = 268). State departments of health and of
the environment were contacted to identify which of these
counties were solely dependent on groundwater for their
drinking water supply, that is, lacking surface water sources
for drinking water. These data produced a set of counties
(𝑁 = 186) that could be included in the analysis. The range
for the median arsenic exposure of these 186 counties was 3–
59 𝜇g/L arsenic.
2.2. Outcome Measure. The outcome data came from the
NCI/EPA report on US County Cancer Mortality Rates and
Trends, 1950–1979 [21]. The lung cancer data in the NCI/EPA
1950–1979 cancer mortality report was presented as counts
and age-adjusted rates (adjusted to the 1970 US population)
for each decade and separately for the four race- gender
demographic groups—white males, white females, nonwhite
males, and nonwhite females. Nonwhites included AfricanAmericans, American Indians, and Asians. Such data existed
for the US, each state, and each county in the 48 states that
comprised the USA in 1950 (i.e., excluding Alaska and Hawaii
which became states in 1959). Lung cancer mortality data that
included at least one lung cancer death and an annual average
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age-adjusted death rate for each of the three decades—1950–
1959, 1960–1969, and 1970–1979—was used as an inclusion
criterion for the outcome of interest.
The Standard Mortality Ratio (SMR) for each study
county served as the outcome metric. The SMR was calculated
as the sum of the observed number of lung cancer deaths over
the three decades divided by the sum of the expected number
of lung cancer deaths by decade. The expected number was
the number of lung cancer deaths that would have been
expected if that county’s population had the same mortality
rate as did its state.
2.3. Covariables. Potential demographic county level covariables of education (percent of non-high school graduates),
rural (percent of the rural), poverty (percent of those below
75% of the poverty level), and income (median household
income) came from the 1970 US census data [22]. Education,
rural, and poverty data were obtained through the National
Historical Geographic Information System (NHGIS) [23].
Nativity (percent of cancer deaths to person born in state)
came from US Vital Statistics 1979 [24]. County-average soil
arsenic levels (including sediment) were available from the
USGS National Geochemical Survey for all 173 counties [25]
and were included as a proxy for dietary arsenic. Countyspecific smoking rates for males and females were available
based on the 1996 Behavioral Risk Factor Surveillance System
(BRFSS) data [26, 27]. The US Census Bureau provided the
county population data [23].
2.4. Analytic Methods. A scatterplot of the county SMRs on
the county median groundwater arsenic levels was visually
examined to assess both linearity of relationships and the
occurrence of disparate elements (outliers). Regression analyses were tested with both a linear and a quadratic term
in order to assess for nonlinearity. The quadratic term to
the model was not found to be significant, which excluded
at least one form of a nonlinear relationship. Populationweighted least square regression analyses adjusted for the size
of each population were conducted to reduce the effect of the
wide range of population sizes across the counties. The 1960
white male and female populations were used to represent the
1950−1979 period as it was more representative of the prior
years. Multiple linear regression analyses were conducted to
determine which covariables were significantly related and to
adjust for their effects. Statistical significance was based on
a two-tailed 𝑝 < 0.05. The multivariate analyses provide a
sensitivity analysis with respect to the examined covariables.
Backward elimination strategy was used to select a final
model based on the 𝑝 = 0.05 significance level. The analysis
began with all the variables included in the model and
followed with sequential removal on the basis of statistical
significance. The final model contained only those variables
that each remained as statistically significant predictors.
Further, hierarchical linear regression analysis was conducted to assess the significance of the unique variance additionally contributed by the median groundwater arsenic level
to the SMRs analyses. Regression analyses were conducted
using Stata 11.0 [28], and scatter plots with trend lines were
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constructed using Excel [29]. As an alternative, a stratified
linear regression relative risk analysis was conducted that
provides a more granular look at the pattern of the SMR
over the exposure range. The SMR for each stratum was the
average of the SMRs for the counties in that stratum, and
the exposure for each stratum was the population-weighted
average of the median exposures for those same counties. The
relative risks were calculated as the ratio of the SMR in the
exposure strata divided by the SMR in the reference exposure
level, a median exposure of 3.0 𝜇g/L.
Analysis was extended to determine the “unit risk,” that
is, the increased lifetime risk of being diagnosed with lung
cancer per lifetime average increased exposure to 1 𝜇g/L
arsenic in drinking water. This unit risk for lung cancer and
drinking water arsenic exposure was derived from the US
data. As the “unit risk” is a linear function in concept and in
use, the unit risk analyses have been conducted using arsenic
level as a linear function. The maximum unit risk is the 95%
upper confidence bound of the unit risk and is the maximum
unit risk that is still compatible with the underlying data.
The coefficient (slope) for arsenic in the regression analyses was converted to a unit risk estimate in a series of steps.
The national background 1950–1979 lung cancer mortality
rates in the NCI/US EPA [21] report (46.8/100,000 PYs for
US white males and 9.3/100,000 PYs for US white females)
were converted to lifetime lung cancer mortality risks with
the assumption of an average 70-year lifetime. This yielded
lifetime lung cancer mortality risks of 0.0327 (46.8/100,000
∗ 70 = 0.0327) for males and of 0.0065 (9.3/100,000 ∗ 70 =
0.0065) for females.
The baseline lifetime mortality risk at zero arsenic level
in drinking water for the study population was the product
of the lifetime mortality risk and the intercept from the
regression model. The lifetime mortality unit risk for arsenic
exposure was the product of the baseline lifetime mortality
risk at zero arsenic level and the coefficient (slope) for the
median arsenic exposures (𝜇g/L).
The lifetime mortality unit risk for arsenic exposure was
then converted to a lifetime incidence unit risk for arsenic
exposure using the SEER data (1975–2010) [30] lung cancer
incidence to mortality ratio of 1.12 for males and 1.34 for
females. The total factor for converting the coefficient (slope)
for lung cancer mortality to a lifetime incidence unit risk was
0.0367 (0.0327 ∗ 1.12 = 0.0367) for males and 0.0087 (0.0065 ∗
1.34 = 0.0087) for females. The maximum lifetime incidence
unit risk for arsenic ingestion (per 𝜇g/L) was the largest unit
risk that would still be consistent with the underlying data
(95% upper confidence bound (95% UCB)). The maximum
unit risk (Max UR) for lifetime lung cancer incidence per
𝜇g/L arsenic ingested was the product of the intercept, the
95% UCB, and the conversion factor.
The maximum URs derived here from the US data for
US males and females were compared with the lung cancer
unit risks predicted in US EPA [5] for the US male (1.9𝐸 − 4)
and for the US female (4.8𝐸 − 4) populations which had been
derived from the southwest Taiwan data [19]. The comparison
assesses whether the unit risks predicted from the SW Taiwan
data are compatible with the observed US data. Sensitivity
analyses were also performed to determine whether the wide
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Table 1: Descriptive table for variables in analysis of lung cancer mortality risk for white males and white females in study counties with
median groundwater arsenic level.
Units
SMR (WM)
SMR (WF)
Median arsenic
exposure

—
—

Mean
Dependent variable
0.9
0.88
Independent variable

𝜇g/L (ppb)

Median

Range

0.89
0.89

(0.42–1.37)
(0.39–1.65)

6.6

4.5

(3.0–59.0)

47.3
68
11
21,789
7.72
57
58
28.4
23.3

46.8
67
9
21,088
6.95
65
68
27.9
22.8

(26.0–74.0)
(5.0–100.0)
(3.0–36.0)
(11,151–37,669)
(1.23–30.95)
(0.0–100.0)
(0.0–100.0)
(20.6–37.0)
(15.0–34.4)

Covariables
Education
Rural
Poverty
Income
Soil/sediment
State born (M)
State born (F)
Current smoke (M)
Current smoke (F)

Percent < HS
Percent of adults
Percent < 75th percentile
Median income ($)
mg/Kg (ppm)
Percent of Ca deaths
Percent of Ca deaths
Percent of adults
Percent of adults

SMR: standardized mortality ratio, HS: high school, HHInc: household income, M: male, F: female, Ca: cancer; two outlier counties (Deer Lodge, MT; Storey,
NV) were excluded.

range of county characteristics (numbers of wells, population,
and area) had a significant effect on the outcome.
Data on nonwhites had not been included in the main
analysis both because the small number of eligible counties
(28 counties for males and 13 counties for females) made them
unlikely to be representative of the nonwhite US population
and because the county covariables (education, poverty,
median household income, and rural) were unlikely to have
been applicable to the nonwhite population. Because of the
small number of counties meeting the outcome criterion for
nonwhite males or females, the analysis in this report was
limited to the data on white males and females.

3. Results
Of the 186 counties that met the exposure criteria, 173
counties (173/186 = 93%) met the outcome criteria for white
males, 133 for white females (133/186 = 71%), 27 for nonwhite
males (27/186 = 15%), and 13 for nonwhite females (13/186 =
7%). The 173 counties with white male data were located in
26 states and included the 133 counties with the white female
data. The analyses presented here have been restricted to the
white population. The median arsenic levels for the counties
with sufficient white lung cancer data ranged from 3 𝜇g/L to
59 𝜇g/L. The slopes were nonsignificant and negative.
Similar analyses were performed for the counties with
sufficient nonwhite data. The median arsenic levels for the
counties with sufficient nonwhite lung cancer data ranged
from 3 𝜇g/L to 17 𝜇g/L. The slopes, also, were nonsignificant
and negative. For those counties with sufficient white and
nonwhite data for males and females, the slopes for white
and nonwhite male lung cancer mortality were similar to each

other, as were the slopes for white and nonwhite female lung
cancer mortality (not shown).
Table 1 shows the descriptive statistics for covariables as
well as those for the dependent variables for lung cancer
(white male SMR and white female SMR) and for the
independent variable (median arsenic exposure). The median
arsenic levels ranged from 3 𝜇g/L to 59 𝜇g/L based on measurements from 7,669 wells in 173 counties with an average of
44 wells per county and a range of 5 to 510 wells per county.
The study counties are distributed generally across the
contiguous 48 states except for the south and northeast
sections (Figure 1). Nevada and Idaho in the west and South
Dakota and Indiana in the north central regions had the most
counties.
3.1. Simple Regression Analysis. The male SMRs ranged from
0.42 to 1.37 with extreme outliers of 1.79 and 2.10. The
two counties (Deer Lodge County, Montana; Storey County,
Nevada) with extreme outliers (𝑍 ≥ 4.0) were excluded from
the analysis. Both Deer Lodge County (arsenic = 59 𝜇g/L) and
Storey County (arsenic = 6 𝜇g/L) had markedly excess lung
cancer mortality for white males, but not for white females,
suggesting an occupational etiology. Deer Lodge County,
Montana, is the site of the Anaconda copper smelter, where
studies have shown that respiratory cancer excess in the
male population was due to high levels of arsenic inhalation
[31, 32]. Storey County, Nevada, was a retirement area for
underground gold miners, a group with known increased
risk for respiratory cancer [33]. This background provides an
explanation for the extreme rates which were observed only
for the males.
The final 171 county analytic dataset for the males contained 33,304 lung cancer deaths, 78 million (78,172,710)
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1.80
1.60
1.40
1.20
1.00
0.80
0.60
0.40
0.20
0.00

y = −0.0020x + 0.897
R2 = 0.0041
p = 0.462

0

Lung cancer SMR

Figure 1: The distribution of study counties across the contiguous
48 states.
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2.25
2.00
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1.25
1.00
0.75
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0.25
0.00

y = −0.0012x + 0.903
R2 = 0.0016
p = 0.602
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Figure 2: White male lung cancer SMRs (1950–1979) by median
groundwater arsenic level (𝜇g/L). Triangle—outlier male SMR (Deer
Lodge County, Montana, and Storey County, Nevada).

person-years of observation, and a 1960 white male population of 2.6 million (2,605,757). Figure 2 shows the scatter
plot of the white male lung cancer SMRs for the 171 counties
analyzed with respect to their median groundwater arsenic
levels. The SMR data for males regressed on the median
groundwater arsenic levels showed a 𝑦-intercept at zero
arsenic of 0.903 (95% CI, 0.864 to 0.942) and a negative but
nonsignificant (𝑝 = 0.602) slope of −0.0012 (95% CI, −0.006
to +0.003). Simple linear regression on the arsenic exposure
data explained less than 0.2% of the variance of the SMR data
for males (𝑅2 = 0.0016).
The female lung cancer SMRs were found to have a range
of 0.36 to 1.65, with no extreme outliers. The final 133 county
analytic dataset for the females contained 7,778 lung cancer
deaths, 76 million (75,696,150) person-years of observation,
and a 1960 white female population of 2.5 million (2,523,205).
Figure 3 shows the scatter plot of the white female lung cancer
SMRs for the 133 counties analyzed with respect to their
median groundwater arsenic level. The SMR data for females
regressed on the median groundwater arsenic levels showed
a 𝑦-intercept at zero arsenic of 0.897 (95% CI, 0.847 to 0.947)
and a nonsignificant (𝑝 = 0.462) negative slope of −0.0020
(95% CI, −0.007 to +0.003). Simple linear regression of the

10
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30
40
50
Median groundwater arsenic level (𝜇g/L)

60

Figure 3: White female lung cancer SMRs (1950–1979) by median
groundwater arsenic level (𝜇g/L).

arsenic exposure data explained about 0.4% of the variance
of the SMR data for females (𝑅2 = 0.0041).
Analyses that excluded the two highest arsenic levels, that
is, of data for arsenic level < 30 𝜇g/L, yielded slopes of 0.000
for males (𝑝 = 0.91) and for females (𝑝 = 0.36) and with
little explanatory power (𝑅2 < 0.004). The maximum unit
risks are calculated to be 2.27𝐸 − 04 and 3.64𝐸 − 05 for males
and females, which reject the EPA predicted unit risk at the
90th and 95th percentiles, respectively.
Sensitivity analyses were carried out with respect to
county characteristics of number of wells, population, and
area. Analyses were restricted to eliminate the more extreme
values of few wells, low population, and large area, each by
one to two orders of magnitude. Sensitivity analyses were
conducted on number of wells per county (≥5 to >50),
population per county (>0.4 K to >5 K), and square miles
per county (<25,000 to <1,500). In all cases, the slopes were
similarly negative, and the intercepts were less than 1.00.
Removal of the more extreme values had no effect on the
analytic results. The slope was independent of data density
(i.e., wells per square mile) with the slope and intercept for
counties above the median (0.0011) and below the median
(0.0013) being essentially equivalent, an issue raised by Ryker
[32].
3.2. Multiple-Regression Analyses. Each white male lung cancer model contained data from 171 counties in 26 states. The
arsenic coefficient (slope) was negative in the unadjusted
model and positive in the adjusted models. Rural was the
only significant variable in the arsenic model with all seven
covariables. The unit risk was calculated to be −4.44𝐸−5 in the
unadjusted model, 1.62𝐸−5 in the model with all covariables,
and 1.05𝐸 − 5 in the model with the significant covariable
(rural). A negative unit risk is interpreted as equal to zero. The
maximum unit risk was 1.05𝐸 − 4 in the unadjusted model,
1.47𝐸 − 4 in the model with all covariables, and 1.72𝐸 − 4
in the model with the significant covariable. Expansion of
the adjusted model to include all seven covariables nearly
doubled the explanatory power from 0.072 to 0.133. The
maximum unit risk in each of the three models was less than
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Table 2: Stratified analysis of male and female lung cancer mortality by median groundwater arsenic level (𝜇g/L).

As
County Counties Cases
Median Wt Males Males
Males
3.0
3.0
49
12,595
3.1–3.9
3.5
15
1,947
4.0–4.9
4.1
25
11,199
5.0–5.9
5.0
18
1,251
6.0–6.9
6.1
16
1,317
7.0–7.9
7.1
11
369
8.0–9.9
8.3
15
1,413
10.0–14.9
11.2
12
1,952
15.0–24.9
20.1
7
868
25.0–59.9 39.7
3
123
3.0
3.0
49
12,595
3.1–9.9
5.4
100
17,496
10.0–59.9
17.9
22
2,943

SMR
Males
0.89
0.91
0.88
0.92
0.91
0.86
0.94
0.84
0.95
0.83
0.89
0.90
0.87

95% CI
Males
(0.84–0.94)
(0.82–0.99)
(0.82–0.94)
(0.81–1.04)
(0.79–1.02)
(0.70–1.01)
(0.85–1.03)
(0.73–0.94)
(0.78–1.12)
(0.53–1.13)
(0.84–0.94)
(0.82–0.99)
(0.82–0.94)

RR
Males
1.00
1.02
0.97
1.05
0.98
0.94
1.10
0.89
1.13
0.88
1.00
1.01
0.98

County Wt Counties Cases
SMR
95% CI
RR
Females Females Females Females Females Females
3.0
42
3,026
0.89
(0.81–0.96)
1.00
3.5
13
455
0.90
(0.77–1.03)
1.02
4.1
21
2,907
0.89
(0.81–0.96)
0.99
5.0
11
235
0.87
(0.73–1.02)
0.98
6.1
11
251
0.93
(0.82–1.05)
1.07
7.2
6
61
1.05
(0.80–1.30)
1.13
8.4
10
223
0.75 (0.58–0.92)
0.71
11.3
10
385
0.87
(0.72–1.02)
1.16
20.4
5
170
0.84
(0.57–1.10)
0.97
41.2
3
31
0.82 (0.67–0.97) 0.98
3.0
49
3,026
0.877 (0.81–0.96)
1.00
5.3
72
4,132
0.890 (0.84–0.94)
1.01
18.8
18
586
0.853 (0.76–0.95) 0.97

County Wt: county weighted, SMR: standardized mortality ratio, CI: confidence interval, RR: relative risk.

3.3. Stratified Analysis. The lung cancer mortality data can
also be aggregated into a stratified analysis (Table 2). This is
analogous to the previously published male bladder cancer
mortality data [16].
With a single exception, each of the SMRs is less than 1.00,
and many of them are statistically significant (i.e., 95% UCL
< 1.00). The SMRs are fairly consistent at about 0.90, probably

1.60
Female lung cancer risk
y = −0.0007x + 1.0088
R2 = 0.0047 p = 0.85

1.40
Lung cancer relative risk

the US EPA [5] predicted unit risk of 1.9𝐸 − 4, rejecting it by
a factor of 10–80% (or an average of 40%).
A model for male lung cancers with all seven covariables
but without arsenic (not shown) as an explanatory variable
had an 𝑅2 of 0.1329, only slightly less than the 𝑅2 = 0.1332
of the model with all seven covariables and arsenic. This
indicated that arsenic increased the explanatory power by less
than 0.05%. Hierarchical analysis showed a 𝑝 value of 0.808
for the arsenic variable.
Each female lung cancer model contained data from
133 counties in 25 states. The arsenic coefficient (slope) was
negative in all three models. Poverty was the only significant
variable in the arsenic model with all seven covariables. The
unit risk was also negative in all three models and statistically
indistinguishable from zero. The maximum unit risk was
2.62𝐸 − 5 in the unadjusted model, 3.32𝐸 − 5 in the model
with all seven covariables, and 2.56𝐸−5 in the model with the
significant covariable (poverty). Expansion of the adjusted
model to include all seven covariables nearly quadrupled the
explanatory power from 0.0246 to 0.0888. The maximum unit
risk in each of the three models was less than the US EPA [5]
predicted unit risk of 4.8𝐸 − 4, rejecting it by a factor of 14–
19-fold.
A model for female lung cancers with all seven covariables
but without arsenic (not shown) as an explanatory variable
had an 𝑅2 of 0.0876, only slightly less than the 𝑅2 = 0.0888
of the model with all seven covariables and arsenic. This
indicted that arsenic increased the explanatory power by only
0.0012 (i.e., 0.12%). Hierarchical analysis showed a 𝑝 value of
0.682 for the arsenic variable.
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Figure 4: Lung cancer relative risks regressed on county-weighted
median groundwater arsenic strata (𝜇g/L).

reflecting that most of the counties had the lung cancer risk
pattern of rural counties rather than those of the areas that
were urbanized with industrial and environmental exposures
and higher smoking rates.
Regression of the relative risks on the average of the
median groundwater arsenic levels in each stratum indicated
a consistent pattern (Figure 4). The relative risks hover
around 1.00. Further aggregation of the data into strata of
3.1–9.9 𝜇g/L and 10.0–59.9 𝜇g/L with 3.0 𝜇g/L as the reference
populations yielded relative risks of 1.01 and 0.98 for males
and 1.01 and 0.97 for females, showing no increase in risk
across the observed exposure range.
For both females and males, the slopes were slightly
negative (−0.001 and −0.002, resp.), and their 𝑝 values (0.846
and 0.345, resp.) were not statistically significant. Visually,
the slope for the female relative risks looks zero and that
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for the male relative risks nearly so. The maximum unit
risks, 1.08𝐸 − 04 for males and 2.62𝐸 − 05 for females, are
calculated to be less than the US EPA [5] predicted unit risks
of 1.9𝐸 − 04 and 4.8𝐸 − 04, respectively. It is noteworthy
that in spite of having consistently low SMRs the relative risk
analysis demonstrates that within this exposure range the
lung cancer risk is not dependent upon the drinking water
arsenic level. The stratified data yield maximum unit risks
that reject the EPA predicted risk by factors of 40% and 7-fold,
respectively.
The results from the regression of the stratified data
(Figure 4) are similar to those from the regressions of the
disaggregated data (Figures 2 and 3). The stratified analysis,
however, shows that the pattern is consistent across the
exposure range and not the consequence of a significantly low
finding at the high end of the exposure range.

4. Discussion
This is the first nationwide US study of the relationship
between lung cancer mortality and the level of arsenic in
the local drinking water supply. It shows no arsenic-related
increase in lung cancer mortality (1950–1979) for US counties
exclusively dependent on groundwater with median arsenic
concentrations in the range of 3–59 𝜇g/L for their drinking
water supply.
This study is of special importance because it provides an
opportunity to evaluate the US EPA [5] male and female lung
cancer risk estimates for arsenic ingestion. US EPA [5, page
131] had developed unit risks for arsenic ingestion (lifetime
lung cancer incidence risk per 𝜇g/L arsenic ingested) of 1.9𝐸−
4 for US males and 4.8𝐸 − 4 for US females, which were based
on the southwest Taiwan data. In contrast, our analyses which
are based on US data found the unit risk to be 1.62𝐸 − 5 for
US males and a negative value (−8.69𝐸 − 6) for US females
in the fully adjusted model. Further, the maximum unit risks
for arsenic ingestion (lifetime lung cancer incidence risks per
𝜇g/L arsenic) were found to be 1.47𝐸 − 4 for US males and
3.32𝐸 − 5 for US females in the fully adjusted models. Thus,
the analysis of the southwest Taiwan data developed in US
EPA [5] significantly overpredicted the lung cancer unit risks
as experienced in the US.
Comparison with Analysis of SW Taiwan Data. The US EPA
[5] lung cancer risk estimates were derived using lung cancer
mortality data from the Morales et al.’s dataset [19] for the
Wu et al.’s [3] study of the 42 villages in the Blackfootendemic area of southwest Taiwan. These villages had median
arsenic exposures that ranged from 10 𝜇g/L to 934 𝜇g/L
and a population-weighted average exposure of 305 𝜇g/L. In
contrast, the US study of 171 and of 133 counties had a median
arsenic exposure range of 3 𝜇g/L to 59 𝜇g/L and a populationweighted average exposure of 5 𝜇g/L. The analysis in this
study demonstrates that the risk estimated from a population
averaging 305 𝜇g/L does not predict the risk experienced by
a population averaging 5 𝜇g/L. Similarly, an analysis of the
southwest Taiwan data excluding the reference population
demonstrated that the risk estimated for a population that
included those with median, mean, or maximum exposures
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above 200 𝜇g/L did not predict the risk among those with
exposures below 100 𝜇g/L [34].
The US study and the SW Taiwan study are both ecological studies that use local well water arsenic data and
that lack individual exposure data; thus, results in each
should be interpreted cautiously. In both cases, the analyses have been based on the median values. The median
values do not incorporate the range of measurements but
do represent a measure of their central tendency. In neither case is there information on what proportions of the
populations used waters of different arsenic levels, so it is
not possible to calculate population-weighted means, and
medians have had to suffice as the representative exposure
measure.
Both our analyses and those of the EPA were conducted
in the 21st century and are based on data from the late 20th
century. Our period of mortality is 1950–1979 and that of the
EPA is 1973–1986, so they are temporally similar. While the
most relevant exposure data for both studies would have been
of drinking water arsenic levels from the late 19th century
to the late 20th century, the earliest extant data are from
1973 to 1998 for the US data and from 1962 to 1964 for
the SW Taiwan data. The USA counties were ascertained
in 2000-2001 to be free of surface waters as drinking water
sources, thus the assumption that the groundwater sources
represented the actual exposure in not confounded with
unascertained surface or piped water sources. In contrast, the
well sampling for the SW Taiwan villages was in 1962–1964,
some years after they had begun to receive surface or piped
water in the 1950s. Thus wells that had been turned off or were
not extant during 1962–1964 would not have been sampled,
casting some doubt as to whether the sampled wells indeed
represented the historic well water sources for the individual
villages.
The US counties had a minimum of five sources and a
median of 17 sources. Most of the villages in the SW Taiwan
villages had measurement from a single source (22 of 42
villages) and the median was 2 sources. The US study was
restricted to those counties that only used groundwater as
their drinking water sources. Bottled water consumption at
that time would not have been a confounding exposure as
consumption in the 70s was only 5% of the consumption
rate in the 2000s [35]. While clean water was brought to
SW Taiwan villages starting in about 1956–1959, the SW
Taiwan study had assumed that the wells sampled in 1964–
1966 comprised all the wells that the villages had ever used
and that no bottled water was used.
While the US study includes county-specific covariables,
the SW Taiwan study had no village-specific covariables
but instead assumed uniformity across all villages for all
variables other than well water arsenic levels. The US study
includes county data on standard demographic covariables—
education, rural, poverty, and income—and the best available data on specifically relevant covariables—soil arsenic,
nativity, and smoking. This would have brought in some
consideration of arsenic exposures from smoking and from
the consumption of locally grown foods but not of other
dietary sources, such as rice. The US analysis here is limited
to the white population, while the SW Taiwan population is
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Taiwanese. The SW Taiwan results were then transposed to a
mainly white population.
Arsenic Exposure Data. National US data on groundwater
arsenic levels did not exist until 1973–1998. Their use here
assumes that there was little change in the levels over the
earlier decades. That assumption is not unreasonable. The
USGS [20] did assess whether groundwater arsenic levels
varied with time and concluded that “there probably is no
relation between arsenic concentration and time for most
wells.” Their time interval may have extended up to two
decades. Similarly, a study in Argentina reported that groundwater arsenic levels showed a high degree of consistency over
a 50-year period [36].
While we have no US data on the steadfastness of
groundwater arsenic levels over a half-century or more, we
are not aware of any additional data from elsewhere that
might examine that. D’Ippoliti et al. from Italy have argued
that arsenic concentrations can be assumed to be stable where
“arsenic contamination in groundwater (is) due to natural
underlying geological processes and (in) the absence of any
arsenic mitigation intervention” [13]. That may be applicable
also for the US. The counties in this study were selected
because they had not developed any surface water drinking
water sources through the year 2000.
The USGS [20] dataset on groundwater arsenic levels in
US counties included measures for the median, the mean,
and the maximum levels, in addition to the 10th, 75th, and
90th percentiles. We used the median level as the measure
of central tendency as the USGS had concluded that the
median level represented “the true center of the data” and
avoided the biased effect that the skewed distribution had
on the mean level [37]. We also conducted analyses using
the 10th, 75th, and 90th percentiles as well as the mean
and the maximum. In those models, all coefficients were
nonsignificant and negative for both male and female lung
cancers with the exception of maximum arsenic which was
nonsignificant and positive (not shown).
Nonwater Sources of Arsenic. Food and soil provide additional
alternative media for arsenic exposure. Again, data were not
available prior to recent years. Xue et al. [38] showed for the
USA an average dietary inorganic arsenic intake of 2 𝜇g/day
using 2003-2004 NHANES data. Similarly, Kurzius-Spencer
et al., using the 2003-2004 NHANES data as well as two
datasets from Arizona (1995–1997 NHEXAS and 2006-2007
BAsES), reported geometric mean dietary inorganic arsenic
intakes of 6–8 𝜇g/day [39, Table 3]. Further, Tao and Bolger
[40, 41], using the 1991–1997 FDA Total Diet Study for Market
Basket data, reported an average total inorganic arsenic intake
of less than 10 𝜇g/day for most people in the US. We have run
the models with assumptions of either 2 or 10 𝜇g/day arsenic
from diet together with an ingestion of 1 or 2 liters of water
per day and found no effect from the assumptions for dietary
contribution.
Xue et al. [38] had found that vegetables were the primary
contributor (24%) to dietary inorganic arsenic. We presumed
that locally grown vegetables were a greater part of the diet
in the earlier years and may have reflected local soil arsenic
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levels. Therefore, we used soil arsenic levels as a proxy for
dietary inorganic arsenic. Two sources for county-averaged
levels of arsenic in the soil—the USGS National Geochemical Survey [25] and USGS Geochemical and Mineralogical
survey [42]—were used as covariables. No effect on the
coefficient (slope), 𝑝 value, or 95% upper confidence limit of
the median groundwater arsenic variable in the model was
found. We found no correlation with soil/sediment values
and groundwater arsenic levels. While a recent US study had
reported an association between soil/sediment arsenic values
and lung cancer [43], we were unable to confirm it using
either their data or ours.
Cigarettes are a known source of arsenic exposure.
Agency for Toxic Substance and Disease Registry [44] reports
that tobacco contains an average arsenic concentration
of 1.5 𝜇g/cigarette and yields a mainstream dosage of 0–
1.4 𝜇g/cigarette (midrange 0.7 𝜇g/cigarette). The American
Lung Association [45] reports that the average daily consumption of cigarettes per adult in 1996 was about 7 cigarettes
per day. This would indicate a daily average consumption
of about 5 𝜇g arsenic per day from cigarettes in the year
for which we give smoking prevalence. This 5 𝜇g/day dosage
would fit within the 2–10 𝜇g/day nondrinking water sources
of arsenic in the calculations above.
Cigarette Smoking. Cigarette smoking may contribute to the
risk both as an additional source of arsenic exposure and for
its effect on lung cancer risk. Smoking data, and in particular
county-specific smoking data, were not available until the
late 1990s. County-specific, gender-specific smoking rates are
now available for the years 1996–2012 from the Behavioral
Risk Factor Surveillance System (BRFSS) conducted by the
Centers for Disease Control and Prevention [26, 27]. We
have used the 1996 data, as they are the earliest available
and closest to the time period of the observed mortality,
and have used the assumption that the distribution of the
1996 county smoking rates reasonably reflects the relative
distribution of the county-specific rates some decades earlier.
We have used the above data to test this assumption by asking
how well the smoking rates for 1996 and 2012 (an interval
of 17 years) correlate. We found the correlation coefficient
for county smoking rates over that 17-year interval to be
0.85 for males and 0.81 for females. Thus, we hold that it
is not unreasonable to assume that the 1996 smoking rates
distribution also reflects the county-specific smoking rates of
previous decades. The US smoking rates were generally about
25% during the years of the BRFSS and about 40% during
the years of the mortality observation [46]. We have assumed
that, in spite of the general drop in the absolute smoking
prevalence, the relative county-specific smoking prevalence
has remained the same or similar.
ATSDR [44] noted that only with high levels of arsenic in
drinking water did cigarette smoking increase the occurrence
of lung cancer, citing cases of BFD disease in SW Taiwan
[47] and exposures with very high arsenic levels [48]. Tsuda
et al. [48] found an increased risk among smokers with
exposure of ≥1,000 𝜇g/L but not at the lower exposure
of 50–990 𝜇g/L. The Putila [43] analysis of soil/sediment
arsenic as a risk factor for lung cancer showed that the
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odds ratio for arsenic (1.004) did not differ whether smoking
was or was not included in the analysis. Further, no significant interaction between smoking and arsenic exposure
has been found at exposure levels below 90–100 𝜇g/L [8,
10]. Additionally, Gebel et al. [49] reported that tobacco
smoking did not have any influence on the contents of
arsenic in urine or hair, and Demir et al. [50] reported no
association between arsenic levels in lung cancer tissues and
smoking status. Our observation of no association between
lung cancer and smoking prevalence is consistent with the
rest of the literature at exposures of less than 60 𝜇g/L
arsenic.
Natality. Both the previous bladder cancer study [16] and the
SW Taiwan study [3] implicitly assumed that individuals were
locally resident throughout most of their lives and at the time
of their death. We have sought information on geographic
mobility for the US counties. One metric that might have
been used was the census data on the proportion of current
residents that had been born in that place. However, those
data are overweighted for the very young. As an alternative,
we developed a metric using place of birth information
on the 1979 US Vital Statistics public access data file for
those who died from cancer (median age 62). We used
as our metric the proportion of county cancer deaths that
occurred to residents who were born in that same state.
This metric was thus weighted to the age-group of interest.
We observed that on average about 65–68% of the county
residents dying from cancer had been born in the same
state, suggesting that migration into the state may not have
been such a major influence on the county cancer mortality
rates.
Demographic Measures. County-specific demographic variables on education, rural, poverty, and income were obtained
from the 1970 US census data. Thus, these data were contemporary with the period of mortality observation. The only
variables that were significant in the multivariable analyses
were rural in the analyses of male lung cancer and poverty in
the analyses of the female lung cancers.
Limitations. Despite our finding that no arsenic-related
increase in lung cancer mortality for US counties is exclusively dependent for their drinking water supply on groundwater with median arsenic concentrations in the range of
3–59 𝜇g/L, there are potential limitations to our study. The
major limitations are that this is an ecological study and
that the county-specific exposure variable and covariable
information are generally for time periods after the period of
mortality (1950–1979). Such data for earlier time periods do
not exist.
The first major limitation of this study is that, a characteristic of ecological studies, per se, all measures are aggregate
data rather than individual data and thus susceptible to
the ecological fallacy. Further, the exposure metric (median
groundwater arsenic concentration for the county) is a
composite measure that does not express the variability in
within-county exposure levels. The working assumption is
then that all residents of the county were exposed to the
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median arsenic level for that county. The outcome measure
(relative lung cancer mortality risk) has considered age, sex,
race, state, and decade of death.
These analyses are based on 1950–1979 mortality data
with exposure and covariable data from the mid-1970s to
the mid-2010s. In order to deal with regional variations in
diagnostic patterns, the county-specific risks were calculated
relative to the risks for their individual states. An alternative
analysis might have been to match counties with other
counties of similar urban/rural status. That, however, would
have required a number of selection assumptions that would
raise their own issues. A second alternative might have been
to use a more recent lung cancer data base. That alternative is
being pursued so that its findings can be compared with these
along with the then-current regulatory analyses.
The second major limitation of this study relates to the
absence of temporal concurrence of the exposure information
and the covariables. The groundwater arsenic data for US
counties were only measured at the end of the 1900s and have
to be presumed to have not changed significantly or relatively
since the beginning of the 1900s. There are no data on which
to assess that presumption and analytic methods at that time
would have been insensitive to the exposure range here.
Similarly, regarding the cigarette smoking prevalence, we
are well familiar with the marked changes nationally over
the decades of the 20th century but we can only assume that
the relative prevalence has not grossly changed in the second
half of the 20th century, which we recognize as a weak but
necessary assumption. For the other covariables, the earliest
available data have been used.
The limitations of the SW Taiwan study that underlies
the US EPA Toxicological Report [19] are generally similar to
those of the US counties study. However, covariables (other
than age and gender) were not obtained but were assumed to
not have varied across the villages or to have been different
for the regional population. No smoking information was
obtained.

4.1. Toxicological Model. Cohen et al. reviewed the toxicological literature evaluating the carcinogenicity of inorganic
arsenic. They provided evidence for a mode-of-action (MOA)
that involved the formation of reactive trivalent metabolites
that interact with critical sulfhydryl groups, thus leading
to cytotoxicity and regenerative cell proliferation [51]. They
state that this MOA implies a nonlinear, threshold doseresponse for both noncancer and cancer endpoints. Other
MOAs might include genotoxicity and/or oxidative stress.
US EPA notes that arsenic and its metabolites have not been
found to induce gene (point) mutations and that a number
of steps in the cytotoxicity-cell regeneration model may be
stimulated by oxidative damage [5, page 99]. Snow et al.
[52] had suggested a hermetic (biphasic) response at low
concentrations, to which US EPA observed that “some lowdose effects (e.g., increased DNA repair) may be protective of
carcinogenesis (and that) other effects (e.g., cell proliferation
or telomerase activation) may . . . (at higher doses) permit
mutant cells to survive by preventing cellular senescence and
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death and . . . (thus enhancing) arsenic’s cancer-promoting
capacity” [19, page 100].
In analyses on the SW Taiwan data that we have published
elsewhere [53, 54], we have demonstrated high risks of both
bladder and lung cancers with high levels (200–1,000 𝜇g/L)
of arsenic in the drinking water. In contrast, our analyses of
the bladder and lung cancer data for the villages in SW Taiwan with low levels (<100 𝜇g/L) demonstrated no exposurerelated increased risk of either bladder or lung cancer in the
10–100 𝜇g/L exposure range. Similar to our findings for the
SW Taiwan villages with low levels of arsenic in the drinking
water, we found no exposure-related increased risk of bladder
cancer mortality in the US county data [16] and now we
demonstrate the same for lung cancers in the US mortality
data.
Other recent epidemiological studies show similar results
at exposures of <100 𝜇g/L as does this ecological study. A
recent case/control study from western USA (California and
Nevada) reported lung cancer odds ratios of 0.75 and 0.84
for exposures of 11–84 𝜇g/L (5-year average, 10-year and 40year lag) compared to ≤10 𝜇g/L [9]. Additionally, a recent
case/control study from Chile with individual exposure levels
all at <100 𝜇g/L and determined over a 65-year period similarly found no significant increased risk for lung cancer across
exposure tertiles (<10.1 𝜇g/L, 10.1–59.9 𝜇g/L, and >59.9 𝜇g/L),
whether lagged 5 years or 40 years (Web Table 4) [11].
The fact that the data from all these studies are consistent
with the threshold model is intriguing, since recent toxicological findings indicate that arsenic carcinogenicity may follow
a two-step process with cytotoxicity being followed by cellular
proliferation and a no-effect level being observed [51].
A variety of studies are beginning to show other toxicological effects related to mechanisms occurring with arsenic
exposures in the hundreds of micrograms per liter but not
below. Niedzwiecki et al. [55] found significant decreases in
global methylation of DNA in peripheral blood monocytes
only at exposure of greater than 300 𝜇g/L in the drinking
water in Bangladesh. Similarly, Karakulak et al. [56] found
that aortic elasticity parameters in arsenic-exposed workers
diminished only when urinary arsenic levels exceeded about
150 𝜇g/L.
4.2. Risk Modeling. This risk modeling has used a linear
model both because that is the underlying assumption of
a unit risk and because an added quadratic term was not
statistically significant (𝑝 value of 0.636 for males and 0.555
for females). The unit risk is, by convention, consensus, and
usage, restricted to be nonnegative, that is, either zero or
positive. The regressions above yielded negative coefficients
and negative best estimates of the unit risk. In no case was
the finding statistically significant. Thus, it is reasonable to
conclude from this modeling that the lung cancer unit risks in
this range of exposure (3–59 𝜇g/L) are indistinguishable from
zero, an observation consistent with the threshold model.
The 95% upper confidence limits of these unit risk estimates
based on the US data were positive and were less than the
lung cancer unit risks predicted in the US EPA [5] model
based on the southwest Taiwan data. Thus, these data are
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inconsistent with the US EPA [5] linear no-threshold model
that significantly overpredicted the lung cancer risks for
the US population from the ingestion of drinking water
containing arsenic in the 3–59 𝜇g/L range.
In contrast, these data are consistent with the results of
a more recent systematic review and metaregression analysis
of lung cancer risk and inorganic arsenic in drinking water
which found no increased lung cancer risk at arsenic exposures below 100–150 𝜇g/L [6]. The metaregression analysis
had found similar results for ecological studies (such as this
one) and for nonecological (case-control and cohort) studies.
Although ecological studies can be susceptible to the ecological fallacy, it is interesting to note that the analytic results and
model fit from the ecological studies were equivalent to those
from the nonecological (i.e., epidemiological) studies.
The US EPA [5] model considered a number of covariables or additional risk factors and then assumed that the
exposures were similar across all the villages and thus
differentially nondistinguishable. We have considered seven
relevant covariables for which county-specific values were
available. We have included them in our analyses. The use of
the standard model that included the seven covariables for
male lung cancers yielded a fit with 𝑝 = 0.003, a positive
unit risk, and a positive maximum unit risk which was less
than the US EPA [5, page 131] predicted risk. The model
explained ∼13% (𝑅2 = 0.1332) of the variability in the SMR
for males. The use of the standard model that included the
seven covariables for female lung cancers yielded a fit with
𝑝 = 0.160, a negative unit risk, and also a positive maximum
unit risk which was less than the US EPA [5] predicted risk.
The model explained ∼10% (𝑅2 = 0.0888) of the variability in
the SMR for females. When the standard model was restricted
to inclusion of the significant covariables (rural in the male
model and poverty in the female model), the explanatory
powers were lower by a two- to fourfold factor but the
maximum unit risks still were lower than those predicted by
the US EPA model.
The observation is that for each linear model the best
estimate of the slope over this exposure range of 3–59 𝜇g/L
arsenic is indistinguishable from zero and a relative risk that
is not greater than 1.0. The same was true when the exposure
range was limited to 3 𝜇g/L to <30 𝜇g/L. This is in contrast
to the significantly positive slope and relative risks for lung
cancer observed in other studies where the exposures are in
the hundreds of 𝜇g/L arsenic. Taken together, these analyses
suggest either a j-shaped, sublinear, or hormetic curve or
alternatively a hockey-stick, or threshold, model. These data
are inadequate to distinguish between these two models.
For the most part, those analyses which in a univariate
analysis show a statistically significant negative slope or
reduced relative risk show in a multiple variable regression
slopes that are indistinguishable from zero or relative risks
indistinguishable from 1.0. Nonetheless, these data, showing
no increased lung cancer risks with exposures below 60 𝜇g/L,
are sufficient to exclude the lung cancer unit risks proposed
by the linear nonthreshold model presented in US EPA [5,
page 131]. Further, the WHO (2001) JECFA1 report [57], using
the 5-stratum NE Taiwan lung cancer data of Chen et al. [8],
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found for a variety of models a de minimis risk range for
the BMD0.5 equivalent to 59–102 𝜇g/L. Thus, our findings are
quite consistent with those of other studies and analyses that
have examined this exposure range.

Research Initiative for Environmental Sciences (Virginia
Polytechnic Institute and State University) for funding.

4.3. Summary. In summary, analysis of the 1950–1979 US
lung cancer mortality data for US counties that were solely
dependent on groundwater for their drinking water sources
found no association between lung cancer mortality and
median groundwater arsenic level over the exposure range of
3 to 59 𝜇g/L arsenic. Almost all of the dose-response slopes
in both the simple and multiple linear regression models
were negative, and all were statistically indistinguishable from
zero. These US county lung cancer mortality data do not
demonstrate an increase in lung cancer risk with respect to
median groundwater arsenic levels over the exposure range
of 3–59 𝜇g/L arsenic. The upper-bound estimates of the risks,
examined in a variety of models, were lower than the risks
that had been predicted from the SW Taiwan data and do not
support those predictions.

[1] National Research Council (NRC), Arsenic in Drinking Water,
National Academy of Sciences, National Academy of Sciences
Press, Washington, DC, USA, 1999.
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